ylates, and immunosuppressants, which often provide symptomatic relief but fail to address underlying immune dysregulation or lead to remission in all patients. The breakthrough immunotherapy and the race to cu
ition) serves as an essential resource for clinicians, researchers, and students alike, providing comprehensive insights into the mechanisms, applications, and future directions of immunotherapy in cancer care. This review delves into the core aspects of this
ve T cell transfer, cancer vaccines, and cytokine therapy, aiming to restore or boost immune system activity to recognize and destroy cancer cells. How do immune checkpoint inhibitors improve cancer treatment outcomes? Immune checkpoint inhibitors blo
